Chlorothiazide Oral Suspension shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-02-10 · last update 2026-02-10
Manufacturers: Salix Pharmaceuticals, a division of Bausch Health US, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12) | Salix Pharmaceuticals, a division of Bausch Health US, LLC | To Be Discontinued | — | Posted 02/10/2026 Updated 02/10/2026 Discontinued 02/10/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)